NeoGenomics Inc. NEO
$10.97
▼ -2.79% 24H
About
NeoGenomics Inc. is a leading cancer diagnostics company specializing in oncology genetics testing and information services. It offers one of the most comprehensive menus of oncology-focused tests worldwide, including next-generation sequencing (NGS), comprehensive genomic profiling, and advanced assays like RaDaR ST f…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees2,500
TickerNEO
Statistics
Market Cap$1.42B
Revenue (TTM)$727.3M
Net Income-$108.0M
Net Margin-14.9%
EPS$-0.77
P/E-13.65
P/S2.00
P/B1.77
EV/EBITDA405.71
ROE-11.6%
Dividend Yield—
Price$10.97
Data: Twelve Data · Revenue = mcap / P/S